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Introduction
The famous physiologist Walter Cannon once said that research is systematic acquisition of new knowledge "which deeply satisfies both the explorer's adventurous spirit and his persistent curiosity." In today's competitive world the 'publish-or-perish' culture has diluted this adventurous spirit. Scientific literature is challenged with the rise of duplicate publications. There has to be a method in this madness which we call research.
Menace of duplicate publication
Duplicate publication has been a challenge for medical journals for numerous years and it often tops the agenda of Editors' meetings. 1 In a survey 3,247 American researchers admitted unethical behaviour in the form of recurring publication (4.7%) and plagiarism (1.4%). 2 We indeed need cross references at times but duplication leads to over inflation of results. For example In a BMJ meta-analysis, the antiemetic efficacy of Ondansetron is over-estimated by 23% because of duplications. 3 The researchers also found 17% of randomised trials and 28% of the patient data in the study to be significantly duplicated.
The International Committee of Medical Journal Editors (ICMJE) describes duplicate (or redundant) publication as:
"…publication of a paper that overlaps substantially with one already published in print or electronic media."
4
A surge in the rise of new journals is correlated with lax standards and it would help preserve the quality of scientific literature if tools were developed to detect duplication as early as possible in the production process.
There are a number of software programs available to identify redundant publications. One of note identified by the Committee on Publication Ethics (COPE) is CrossCheck, a plagiarism detection service. It is offered by the independent publishers' membership association CrossRef. 5 The CrossCheck user community of over 50 publishers consists of global scientific, medical and technical publishers and societies using iThenticate technology in Garner's team uses eTBLAST to build Déjà vu, a continually updated database that holds over one hundred thousand abstracts listed in Medline that seem highly similar. This watchdog has so far found dozens of near-100% clone papers. 9 The researchers have put these numerous suspected duplicates in the public domain via Déjà vu. This is freely accessible and users are encouraged to contact the researchers about the authenticity of these suspected duplicates. Garner has started contacting the editors and authors of the duplicates Déjà vu has identified, and is submitting the results for publication.
Key features
The key feature of eTBLAST is a 'Biomedical Acronym Resolver' and more importantly a 'Pair Comparison.' In the latter, two different paragraphs from different sources are evaluated for similarity as part of biomedical text comparison. It was this unique feature which enabled it to catch >87.5% text similarity between a Nepalese article and an American article. The editors of the Nepalese journal investigated and penalized the author after eTBLAST's email. 10 The Déjà vu interface is designed using python (http://python.org) and the Django web framework (http://djangoproject.com). Data are stored in a backend MySQL Database (http://mysql.com) within the Garnerian innovation lab. 11 The data entries are retrieved using PubMed ID, first article and the last article of similarity, the publication lag between these two, languages of both these articles and their 'Similarity Ratio' calculated by dividing the "Duplicate Score" by the "Identity score." The database also indicates whether or not the duplications have shared authors.
The creators of this tool, which functions as a sort of ethical ombudsman, observed that duplications were predominantly in journals with low impact factor and that these articles were rarely cited. Escaping detection may be more likely because of low visibility of the journal. 12 A further increased tendency was noticed in which reviews based on a previous publication duplicated matter from the first publication. This was easily picked up by the simple interface of Déjà vu.
In an effort to further enhance the sensitivity, Garner's team has used 'statistically improbable phrases' (SIPs) for assistance in identifying duplicate content. The new innovation yields a much better precision of 78.9% in comparison to 50.3% for eTBLAST. 13 
Recent events
Nature reported that an immunologist's review article is to be retracted from an Iranian journal following allegations of duplicate publication. 14 eTBLAST found that many paragraphs were lifted from Farsi-language forums and blogs in Iran. Déjà vu claimed about 85% similarity to five different papers by other writers. The author of one of the original paper quotes "The article is a veritable patchwork of other people's work, word for word, grammatical error for grammatical error." 14 In defence, the tainted Immunologist blamed it on her student and did not respond to e-mail queries from Nature.
Déjà vu identified that French gerontologist's entire paper had been plagiarised in Korean Journal of Biological Sciences . 15 It was reported to the editors of Experimental Gerontology who tried to investigate, but without any success. A problem confronting those working to identify plagiarism is that many journal editors seem reluctant to pursue the cases of alleged plagiarism. A previous study from Garner's lab searched MEDLINE abstract from the previous 12 years with eTBLAST and found over one hundred thousand duplicate citations with the same authors. 16 The false positive rate was only 1% in this study and the duplicate entries have been deposited in the Déjà vu repository. To take a simple example, PubMed shows articles with same title and authors when you search "Toward more uniform conflict disclosures: the updated ICMJE Conflict of Interest Reporting Form." These may be sensed as duplicate citation by an electronic database but the fact is that these are the guidelines which are adopted and published by several cooperating journals in the larger interest of the public. Hence it is advisable to do a manual verification first before claiming scientific misconduct.
Conclusions
The combination of the freely available eTBLAST tool and Déjà vu database can be a deterrent to unethical practices and is a positive step forward in making such detection easier for authors, editors and reviewers. 18, 19 Journals should make use of this freely available software to ensure high ethical standards.
